{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:09:03Z","timestamp":1791306543226,"version":"4.3.1"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T00:00:00Z","timestamp":1622592000000},"content-version":"vor","delay-in-days":152,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006034","name":"University of Southern California","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006034","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer&apos;s Association","doi-asserted-by":"publisher","award":["2019-AACSF-642998"],"award-info":[{"award-number":["2019-AACSF-642998"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015725","name":"IXICO","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AG024904"],"award-info":[{"award-number":["U01 AG024904"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007333","name":"Alzheimer&apos;s Disease Neuroimaging Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007333","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-12-2-0012"],"award-info":[{"award-number":["W81XWH-12-2-0012"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009804","name":"Northern California Institute for Research and Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014400","name":"Fujirebio US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014400","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005205","name":"Janssen Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013327","name":"H. Lundbeck A\/S","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013327","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroImage: Clinical"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.nicl.2021.102717","type":"journal-article","created":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T21:29:54Z","timestamp":1622928594000},"page":"102717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Oh brother, where art tau? Amyloid, neurodegeneration, and cognitive decline without elevated tau"],"prefix":"10.1016","volume":"31","author":[{"given":"Lauren E.","family":"McCollum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhitsu R.","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"de Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieqiong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon X.","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.M.","family":"Wisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Yushkevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Wolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.nicl.2021.102717_b0005","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/ana.24903","article-title":"Outcomes after diagnosis of mild cognitive impairment in a large autopsy series","volume":"81","author":"Abner","year":"2017","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.nicl.2021.102717_b0010","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neuron.2019.10.010","article-title":"Amyloid-Beta (Abeta) plaques promote seeding and spreading of alpha-synuclein and tau in a mouse model of lewy body disorders with abeta pathology","volume":"105","author":"Bassil","year":"2020","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.nicl.2021.102717_b0015","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/13803399508406584","article-title":"Semantic memory in Alzheimer's disease: An analysis of category fluency","volume":"17","author":"Binetti","year":"1995","journal-title":"J. Clin. Exp. Neuropsychol."},{"issue":"5","key":"10.1016\/j.nicl.2021.102717_b0020","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jalz.2015.09.009","article-title":"Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of beta-amyloid (1\u201342) in human cerebrospinal fluid","volume":"12","author":"Bittner","year":"2016","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.nicl.2021.102717_b0025","doi-asserted-by":"crossref","first-page":"19024","DOI":"10.1038\/s41598-019-54204-z","article-title":"Predicting clinical decline and conversion to Alzheimer's disease or dementia using novel Elecsys Abeta(1\u201342), pTau and tTau CSF immunoassays","volume":"9","author":"Blennow","year":"2019","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.nicl.2021.102717_b0030","first-page":"804","article-title":"Varied effects of age-related neuropathologies on the trajectory of late life cognitive decline","volume":"140","author":"Boyle","year":"2017","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.nicl.2021.102717_b0035","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.nicl.2021.102717_b0040","doi-asserted-by":"crossref","first-page":"248","DOI":"10.14283\/jpad.2019.25","article-title":"Application of the NIA-AA Research Framework: Towards a biological definition of Alzheimer's disease using cerebrospinal fluid biomarkers in the AIBL Study","volume":"6","author":"Burnham","year":"2019","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.nicl.2021.102717_b0045","doi-asserted-by":"crossref","unstructured":"Caillaud M, Hudon C, Boller B, Brambati S, Duchesne S, Lorrain D, et al. Evidence of a Relation Between Hippocampal Volume, White Matter Hyperintensities, and Cognition in Subjective Cognitive Decline and Mild Cognitive Impairment. J Gerontol B Psychol Sci Soc Sci 2019.","DOI":"10.1093\/geronb\/gbz120"},{"key":"10.1016\/j.nicl.2021.102717_b0050","doi-asserted-by":"crossref","unstructured":"Carriere I, Fourrier-Reglat A, Dartigues JF, Rouaud O, Pasquier F, Ritchie K, et al. Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. Arch Intern Med 2009; 169(14): 1317-24.","DOI":"10.1001\/archinternmed.2009.229"},{"issue":"8","key":"10.1016\/j.nicl.2021.102717_b0055","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1161\/STROKEAHA.116.012999","article-title":"Cerebral amyloid angiopathy is associated with executive dysfunction and mild cognitive impairment","volume":"47","author":"Case","year":"2016","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/j.nicl.2021.102717_b0060","doi-asserted-by":"crossref","first-page":"e754","DOI":"10.1212\/WNL.0000000000005030","article-title":"Core cerebrospinal fluid biomarker profile in cerebral amyloid angiopathy: A meta-analysis","volume":"90","author":"Charidimou","year":"2018","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.nicl.2021.102717_b0065","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/1097-4679(198707)43:4<402::AID-JCLP2270430411>3.0.CO;2-E","article-title":"Relationships between parts A and B of the Trail Making Test","volume":"43","author":"Corrigan","year":"1987","journal-title":"J. Clin. Psychol."},{"issue":"5","key":"10.1016\/j.nicl.2021.102717_b0070","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/alz.12233","article-title":"ATN incorporating cerebrospinal fluid neurofilament light chain detects frontotemporal lobar degeneration","volume":"17","author":"Cousins","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.nicl.2021.102717_b0075","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.neuroimage.2017.06.009","article-title":"Performance comparison of 10 different classification techniques in segmenting white matter hyperintensities in aging","volume":"157","author":"Dadar","year":"2017","journal-title":"Neuroimage"},{"issue":"3","key":"10.1016\/j.nicl.2021.102717_b0080","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.neuroimage.2008.12.016","article-title":"Registration based cortical thickness measurement","volume":"45","author":"Das","year":"2009","journal-title":"Neuroimage"},{"issue":"2","key":"10.1016\/j.nicl.2021.102717_b0085","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.neuroimage.2012.01.098","article-title":"Measuring longitudinal change in the hippocampal formation from in vivo high-resolution T2-weighted MRI","volume":"60","author":"Das","year":"2012","journal-title":"Neuroimage"},{"issue":"6","key":"10.1016\/j.nicl.2021.102717_b0090","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/alz.12079","article-title":"Contribution of mixed pathology to medial temporal lobe atrophy in Alzheimer's disease","volume":"16","author":"Flores","year":"2020","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.nicl.2021.102717_b0095","doi-asserted-by":"crossref","unstructured":"Dickerson BC, Bakkour A, Salat DH, Feczko E, Pacheco J, Greve DN, et al. The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex 2009; 19(3): 497-510.","DOI":"10.1093\/cercor\/bhn113"},{"issue":"3","key":"10.1016\/j.nicl.2021.102717_b0100","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/hipo.22690","article-title":"White matter hyperintensities are associated with disproportionate progressive hippocampal atrophy","volume":"27","author":"Fiford","year":"2017","journal-title":"Hippocampus"},{"issue":"10","key":"10.1016\/j.nicl.2021.102717_b0105","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1001\/jamaneurol.2016.2642","article-title":"Longitudinal beta-Amyloid deposition and hippocampal volume in preclinical alzheimer disease and suspected non-alzheimer disease pathophysiology","volume":"73","author":"Gordon","year":"2016","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.nicl.2021.102717_b0110","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41582-019-0281-2","article-title":"Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways","volume":"16","author":"Greenberg","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nicl.2021.102717_b0115","article-title":"Distinct effects of beta-amyloid and tau on cortical thickness in cognitively healthy older adults","author":"Harrison","year":"2020","journal-title":"Alzheimers Dement"},{"issue":"4","key":"10.1016\/j.nicl.2021.102717_b0120","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"6","key":"10.1016\/j.nicl.2021.102717_b0125","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/ana.22628","article-title":"An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease","volume":"71","author":"Jack","year":"2012","journal-title":"Ann. Neurol."},{"issue":"23","key":"10.1016\/j.nicl.2021.102717_b0130","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1001\/jama.2019.7437","article-title":"Associations of amyloid, tau, and neurodegeneration biomarker profiles with rates of memory decline among individuals without dementia","volume":"321","author":"Jack","year":"2019","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.nicl.2021.102717_b0135","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1474-4422(17)30077-7","article-title":"Age-specific and sex-specific prevalence of cerebral beta-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50\u201395 years: A cross-sectional study","volume":"16","author":"Jack","year":"2017","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.nicl.2021.102717_b0140","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/archneur.63.5.674","article-title":"Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia","volume":"63","author":"Jicha","year":"2006","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.nicl.2021.102717_b0145","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2967\/jnumed.114.148981","article-title":"Measurement of longitudinal beta-amyloid change with 18F-florbetapir PET and standardized uptake value ratios","volume":"56","author":"Landau","year":"2015","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.nicl.2021.102717_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2018.05.035","article-title":"The hippocampal longitudinal axis-relevance for underlying tau and TDP-43 pathology","volume":"70","author":"Llad\u00f3","year":"2018","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.nicl.2021.102717_b0155","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1006\/brcg.1997.0923","article-title":"Differences between Alzheimer's disease and vascular dementia on information processing measures","volume":"34","author":"Mendez","year":"1997","journal-title":"Brain Cogn."},{"key":"10.1016\/j.nicl.2021.102717_b0160","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.nicl.2016.12.011","article-title":"Alzheimer's Disease Neuroimaging I. Rey's Auditory Verbal Learning Test scores can be predicted from whole brain MRI in Alzheimer's disease","volume":"13","author":"Moradi","year":"2017","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.nicl.2021.102717_b0165","doi-asserted-by":"crossref","unstructured":"Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K, et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain 2019; 142(6): 1503-27.","DOI":"10.1093\/brain\/awz186"},{"issue":"3","key":"10.1016\/j.nicl.2021.102717_b0170","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"J. Intern. Med."},{"issue":"2, Dementia","key":"10.1016\/j.nicl.2021.102717_b0175","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1212\/CON.0000000000000313","article-title":"Mild Cognitive Impairment","volume":"22","author":"Petersen","year":"2016","journal-title":"Continuum (Minneap Minn)"},{"issue":"1\u20132","key":"10.1016\/j.nicl.2021.102717_b0180","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000448243","article-title":"Impact of Alzheimer's Disease, lewy body and vascular co-pathologies on clinical transition to dementia in a national autopsy cohort","volume":"42","author":"Pillai","year":"2016","journal-title":"Dement. Geriatr. Cogn. Disord."},{"issue":"3","key":"10.1016\/j.nicl.2021.102717_b0185","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nrneurol.2015.10","article-title":"White matter hyperintensities, cognitive impairment and dementia: An update","volume":"11","author":"Prins","year":"2015","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.nicl.2021.102717_b0190","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-019-0521-0","article-title":"Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: A longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set","volume":"11","author":"Puzo","year":"2019","journal-title":"Alzheimers Res. Ther."},{"issue":"5","key":"10.1016\/j.nicl.2021.102717_b0195","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","article-title":"PET imaging of tau deposition in the aging human brain","volume":"89","author":"Sch\u00f6ll","year":"2016","journal-title":"Neuron"},{"issue":"10","key":"10.1016\/j.nicl.2021.102717_b0200","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/jamaneurol.2015.1633","article-title":"Alzheimer's Disease Neuroimaging I. Comparison of visual and quantitative florbetapir F 18 Positron emission tomography analysis in predicting mild cognitive impairment outcomes","volume":"72","author":"Schreiber","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nicl.2021.102717_b0205","first-page":"239","article-title":"Fully-automated white matter hyperintensity detection with anatomical prior knowledge and without FLAIR","volume":"21","author":"Schwarz","year":"2009","journal-title":"Inf Process Med. Imag."},{"key":"10.1016\/j.nicl.2021.102717_b0210","unstructured":"Shaw L. Implementation of fully automated immunoassays for CSF A\u03b21-42, t-tau and p-tau181 in the Alzheimer\u2019s Disease Neuroimaging Initiative. [cited; Available from: https:\/\/www.alz.washington.edu\/NONMEMBER\/SPR18\/BioMarker\/SHAW.pdf."},{"issue":"4","key":"10.1016\/j.nicl.2021.102717_b0215","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects","volume":"65","author":"Shaw","year":"2009","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.nicl.2021.102717_b0220","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00401-011-0808-0","article-title":"Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI","volume":"121","author":"Shaw","year":"2011","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.nicl.2021.102717_b0225","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neuroimage.2008.03.061","article-title":"Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference","volume":"44","author":"Smith","year":"2009","journal-title":"Neuroimage"},{"issue":"5\u20138","key":"10.1016\/j.nicl.2021.102717_b0230","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13195-014-0077-y","article-title":"Evaluating the relationship between amyloid-beta and alpha-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson's disease","volume":"6","author":"Swirski","year":"2014","journal-title":"Alzheimers Res. Ther."},{"issue":"2","key":"10.1016\/j.nicl.2021.102717_b0235","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0887-6177(03)00039-8","article-title":"Trail Making Test A and B: normative data stratified by age and education","volume":"19","author":"Tombaugh","year":"2004","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.nicl.2021.102717_b0240","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.neuroimage.2014.05.044","article-title":"Large-scale evaluation of ANTs and FreeSurfer cortical thickness measurements","volume":"99","author":"Tustison","year":"2014","journal-title":"Neuroimage"},{"issue":"12","key":"10.1016\/j.nicl.2021.102717_b0245","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1016\/j.neurobiolaging.2015.08.029","article-title":"Suspected non-AD pathology in mild cognitive impairment","volume":"36","author":"Wisse","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nicl.2021.102717_b0250","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.neurobiolaging.2016.09.011","article-title":"Alzheimer's Disease Neuroimaging I. Medial temporal lobe subregional morphometry using high resolution MRI in Alzheimer's disease","volume":"49","author":"Wolk","year":"2017","journal-title":"Neurobiol. Aging"},{"issue":"9","key":"10.1016\/j.nicl.2021.102717_b0255","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1001\/jamaneurol.2018.0894","article-title":"Use of Flutemetamol F 18-Labeled positron emission tomography and other biomarkers to assess risk of clinical progression in patients with amnestic Mild Cognitive Impairment","volume":"75","author":"Wolk","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nicl.2021.102717_b0260","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neuroimage.2016.09.070","article-title":"Multi-template analysis of human perirhinal cortex in brain MRI: Explicitly accounting for anatomical variability","volume":"144","author":"Xie","year":"2017","journal-title":"Neuroimage"},{"issue":"12","key":"10.1016\/j.nicl.2021.102717_b0265","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1002\/hbm.24607","article-title":"Automated segmentation of medial temporal lobe subregions on in vivo T1-weighted MRI in early stages of Alzheimer's disease","volume":"40","author":"Xie","year":"2019","journal-title":"Hum. Brain Mapp."},{"issue":"9","key":"10.1016\/j.nicl.2021.102717_b0270","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.jalz.2019.05.006","article-title":"Frequency and longitudinal clinical outcomes of Alzheimer's AT(N) biomarker profiles: A longitudinal study","volume":"15","author":"Yu","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.nicl.2021.102717_b0275","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/hbm.22627","article-title":"Automated volumetry and regional thickness analysis of hippocampal subfields and medial temporal cortical structures in mild cognitive impairment","volume":"36","author":"Yushkevich","year":"2015","journal-title":"Hum. Brain Mapp."}],"container-title":["NeuroImage: Clinical"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158221001613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158221001613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:37:50Z","timestamp":1761971870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213158221001613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":55,"alternative-id":["S2213158221001613"],"URL":"https:\/\/doi.org\/10.1016\/j.nicl.2021.102717","relation":{},"ISSN":["2213-1582"],"issn-type":[{"value":"2213-1582","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oh brother, where art tau? Amyloid, neurodegeneration, and cognitive decline without elevated tau","name":"articletitle","label":"Article Title"},{"value":"NeuroImage: Clinical","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nicl.2021.102717","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102717"}}